Cell & Gene

Personal Perspectives

Jean-Christophe Hyvert

Cell & Gene

Across the Cell & Gene Technologies (CGT), Personalized Medicine and Bioscience businesses, we continue to grow in response to market demand, while developing new and differentiated tools and technologies for emerging modalities. The CGT business grew significantly over the course of 2020, by advancing the commercialization of multiple programs while initiating several new Investigational New Drugs (INDs) and continuing to industrialize operations. Double-digit growth rates have been maintained in both Viral Vector and Cell Therapy across development services and cGMP supply.

Discover More